Estimated Wasteful Spending on Aducanumab Dispensing in the U.S. Medicare Population
Aducanumab, a weight-dosed Alzheimer ' s drug, is available in two fixed-dose vial sizes. This may result in large amounts of discarded drug and wasteful spending. More-efficient vial sizes could save Medicare money if the drug is approved for widespread use.
Source: RAND Research Health and Health Care - Category: Health Management Authors: Carlos Irwin A. Oronce; Julia Cave Arbanas; Mei Leng; Bruce E. Landon; Cheryl L. Damberg; Catherine A. Sarkisian; John N. Mafi Source Type: research